Advertisement
x
Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardInsightsMedcastPeers & Perspectives
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Michael J. Rovito PhD, CHES, FMHI

  1. Home
  2. /
  3. authors
  4. /
  5. michael-j-rovito-phd-ches-fmhi
Advertisement

Articles by Michael J. Rovito PhD, CHES, FMHI

Testis Ca screening: Why USPSTF ‘D’ grade is misguided

ByMichael J. Rovito PhD, CHES, FMHI,Ajay K. Nangia, MBBS
February 14th 2019

No evidence currently exists to suggest screening is either harmful or beneficial.

Advertisement

Latest Updated Articles

  • Testis Ca screening: Why USPSTF ‘D’ grade is misguided
    Testis Ca screening: Why USPSTF ‘D’ grade is misguided

    Published: February 14th 2019 | Updated:



Advertisement
Advertisement

Trending on Urology Times

1

Trial launches of neuromodulation therapy for erectile dysfunction after radical prostatectomy

2

PROSTOX ultra launches on US market following new data presented at ASTRO 2025

3

Published data show benefit of niraparib with AAP in HRR-deficient mCSPC

4

Rectal diazepam eases instillation of nadofaragene firadenovec in NMIBC

5

Integrating chemoablation into everyday NMIBC practice

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us